2015
DOI: 10.1183/13993003.00577-2014
|View full text |Cite
|
Sign up to set email alerts
|

Blood stem cell transplantation to treat cystic lung light chain deposition disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 14 publications
1
7
0
Order By: Relevance
“…12 According to the characteristic clinical, radiologic, and molecular analyses, Colombat et al 11,12 claimed that CL-LCDD is a separate clinicopathologic entity of localized lung disease. Another case was reported by Borgne et al 7 in 2015, which was secondary to lymphoplasmacytic lymphoma and treated successfully with chemotherapy and autologous peripheral blood stem cell transplantation (autoPBSCT).…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…12 According to the characteristic clinical, radiologic, and molecular analyses, Colombat et al 11,12 claimed that CL-LCDD is a separate clinicopathologic entity of localized lung disease. Another case was reported by Borgne et al 7 in 2015, which was secondary to lymphoplasmacytic lymphoma and treated successfully with chemotherapy and autologous peripheral blood stem cell transplantation (autoPBSCT).…”
mentioning
confidence: 99%
“…3 To date, there have been 46 reported cases of pulmonary light chain deposition disease (PLCDD). 6,7 The pulmonary involvement of light chain deposits has been mainly reported as part of a systemic disorder, whereas in a few cases the disease was limited to the lungs. 6 Some clinical features of LCDD associated with the respiratory organs have been identified, including nodules, cysts, airway involvement, 8 and bronchiectasis.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Pulmonary LCDD is an indolent or slowly progressive disease [203]. No recurrence after a 4-year follow-up was observed after lung transplantation [201,207]. Unlike localized disease, treatment of systemic LCDD aims at reducing the serum free light chain level to limit lung deposits.…”
Section: Pulmonary Light-chain Deposition Diseasementioning
confidence: 99%
“…Optimal treatment remains to be defined. Chemotherapy can be associated with peripheral blood stem cell transplantation [207]. …”
Section: Pulmonary Light-chain Deposition Diseasementioning
confidence: 99%